APMD
Apnimed, Inc.
There isn't enough reported data to score APMD yet.
APMD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate APMD's fundamentals.
APMD PE Valuation
APMD has no meaningful PE right now: it lost money over the past year.
APMD Forward outlook
There aren't enough analyst estimates for APMD to show an outlook.
APMD Earnings Per Share
APMD Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -97% | N/A |
APMD Free Cash Flow
APMD Net Leverage
APMD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
APMD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 6.9 | Oversold |
APMD's weekly RSI is 55 (neutral) and its Stochastic is 7 (oversold).
APMD PE vs Healthcare Sector
APMD has no meaningful PE right now: it lost money over the past year.
APMD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.3 | 8.9% below |
APMD is in a downtrend: it's below all one of its weekly moving averages, and 8.9% below its 8-week average.
APMD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $25.0 | $16.6 | -33% |
It's down 33% so far in 2026.